| related words |
| screening |
| nda |
| tarceva |
| personalized |
| injunctive |
| denial |
| formulation |
| freedom |
| hi |
| capsule |
| diabetes |
| oral |
| stent |
| tm |
| zegerid |
| multiferon |
| medication |
| rigorous |
| commence |
| soliris |
|
| related documents |
| 885725--2/26/2010--BOSTON_SCIENTIFIC_CORP |
| 1800--2/22/2006--ABBOTT_LABORATORIES |
| 1123695--3/31/2008--IMARX_THERAPEUTICS_INC |
| 874015--3/13/2008--ISIS_PHARMACEUTICALS_INC |
| 1800--2/19/2008--ABBOTT_LABORATORIES |
| 1274057--3/15/2006--HOSPIRA_INC |
| 1103837--3/29/2006--CROWN_MEDIA_HOLDINGS_INC |
| 356830--2/6/2008--OSCIENT_PHARMACEUTICALS_CORP |
| 356830--3/15/2007--OSCIENT_PHARMACEUTICALS_CORP |
| 1093557--2/27/2007--DEXCOM_INC |
| 1145197--3/9/2010--INSULET_CORP |
| 1428156--3/10/2010--Celera_CORP |
| 1800--2/19/2010--ABBOTT_LABORATORIES |
| 356830--3/25/2009--OSCIENT_PHARMACEUTICALS_CORP |
| 1145197--3/16/2009--INSULET_CORP |
| 1145197--3/20/2008--INSULET_CORP |
| 1800--2/20/2009--ABBOTT_LABORATORIES |
| 1800--2/23/2007--ABBOTT_LABORATORIES |
|
| related topics |
| {product, candidate, development} |
| {property, intellectual, protect} |
| {financial, litigation, operation} |
| {regulation, government, change} |
| {operation, international, foreign} |
| {cost, operation, labor} |
| {product, liability, claim} |
| {competitive, industry, competition} |
| {gas, price, oil} |
| {investment, property, distribution} |
| {cost, regulation, environmental} |
| {control, financial, internal} |
| {interest, director, officer} |
| {tax, income, asset} |
| {condition, economic, financial} |
| {cost, contract, operation} |
| {loss, insurance, financial} |
| {product, market, service} |
| {acquisition, growth, future} |
| {customer, product, revenue} |
|